TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Tarsus to Report Third Quarter 2025 Financial Results on Tuesday, November 4, 2025

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Tarsus Pharmaceuticals, Inc.
Tarsus to Report Third Quarter 2025 Financial Results on Tuesday, November 4, 2025

Tarsus Pharmaceuticals will host a live webcast on November 4, 2025, to report its third quarter 2025 financial results and provide a corporate update. The company has FDA-approved XDEMVY for Demodex blepharitis and is developing additional treatments for eye care and infectious disease prevention.

Insights
CYCU   neutral

Mentioned as a partnership partner for AI-enhanced cybersecurity joint program


TARS   positive

Company is reporting record quarterly net product sales, expanding its product pipeline, and hosting an investor update, indicating growth and strategic development